CECAD Cologne
Chrysanthi Moschandrea is a postdoctoral researcher at CECAD Cologne since August 2022, currently working in the Frezza lab. Prior to this role, Moschandrea completed a PhD as a researcher at the University of Cologne from October 2017 to June 2022 in the Pasparakis Lab. Additional experience includes a research fellowship at CECAD Cologne and a master's dissertation project at the University of Liverpool, focusing on long non-coding RNA deregulation in lung cancer. Earlier research positions include a research assistant role at the University of Crete and internships at the University of Düsseldorf and Creta InterClinic Hospital. Chrysanthi Moschandrea holds a PhD in Molecular Genetics from the University of Cologne, a master’s degree in the Molecular Basis of Human Diseases from the University of Crete, and a bachelor’s degree in Biochemistry and Biotechnology from the University of Thessaly.
This person is not in the org chart
This person is not in any teams
CECAD Cologne
The Cologne Cluster of Excellence on Cellular stress responses in Aging-associated Diseases – short CECAD – is a DFG-funded Cluster of Excellence dedicated to unravelling the underlying mechanisms of aging and aging-associated diseases. Aging is a lifelong process and root for a range of chronic diseases such as cancer, diabetes, cardiovascular diseases, renal failure, and neurodegenerative disorders. With the increasing life expectancy in societies, aging-associated diseases pose a major societal challenge with a far-reaching economic impact. CECAD addresses that challenge by exploring the molecular basis of the aging process and developing new therapeutic concepts for aging-associated diseases. With more than 400 basic and clinician scientists working at the University of Cologne, the Cologne University Hospital, the Max Planck Institutes for Metabolism Research and Biology of Ageing, and the German Center for Neurodegenerative Diseases (DZNE), CECAD is one of the largest academic centers for aging research in Europe. CECAD is devoted to biomedical aging research, training young scientists for the challenges of the aging society, and translating discoveries into clinical practice. The Cologne Graduate School on Aging is training PhD students from 22 countries. CECAD’s translational platform follows the bench to bedside and back approach to derive therapies from discovery science and address new clinical challenges by basic research. CECAD hosts a wide range of cutting edge technological platforms including imaging, genomics & bioinformatics, proteomics, lipidomics, metabolomics and in vivo research. CECAD is devoted to promote researchers at all stages of their career from training undergraduate and graduate students, to mentoring postdocs and group leaders. Our scientific community is particularly aiming to advance diversity and support the careers of female scientists at all levels and generate an inclusive and family friendly work environment.